Internal Medicine · Alliance, NE
NPI
1811071442
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
0
Medicare group memberships
Hospitals
4
Hospital affiliations
723 Flack Ave
Alliance, NE, 69301
Phone (308) 225-4498
Medicare paid, 2024
$134K
8,587 services
Medicare patients, 2024
375
Average age 74
Drug cost, 2024
$1.0M
16,512 prescriptions
Company payments, 2025
$120
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by William V Fattig was code J0696 (injection, ceftriaxone sodium, per 250 mg), 2,196 times for 56 patients. In total William V Fattig billed 8,587 services in 41 codes, and Medicare paid $134K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-08-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 2,196 | 56 | $0.33 | $729 |
| 96372 Injection Administration | Office | 1,558 | 123 | $9.37 | $15K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,334 | 36 | $0.08 | $111 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 963 | 27 | $0.50 | $478 |
| 99214 Office E&M - Established | Office | 782 | 258 | $79.79 | $62K |
| 36415 Venipuncture Blood Collection | Office | 531 | 233 | $4.67 | $2,482 |
| 99215 Office E&M - Established | Office | 219 | 110 | $119.15 | $26K |
| 99213 Office E&M - Established | Office | 187 | 137 | $49.95 | $9,340 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 169 | 27 | $0.66 | $112 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 132 | 40 | $0.79 | $105 |
| 99457 E&M - Miscellaneous | Office | 93 | 11 | $32.00 | $2,976 |
| 99454 E&M - Miscellaneous | Office | 74 | 11 | $32.44 | $2,401 |
| 99309 SNF E&M | Office | 58 | 17 | $69.99 | $4,060 |
| 93000 Electrocardiogram | Office | 45 | 42 | $9.51 | $428 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 18 | 18 | $108.64 | $1,956 |
By year: 2022 $146K for 7,621 services; 2023 $142K for 8,641 services; 2024 $134K for 8,587 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 531 | 233 | $4.67 | $2,482 |
Medicare prescription drug claims, 2024
In 2024, the drug William V Fattig prescribed most often to Medicare patients was Lisinopril, with 626 prescriptions and refills. In total William V Fattig wrote 16,512 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lisinopril Generic | 626 | 925 | 100 | $2,421 |
| Atorvastatin Calcium Generic | 609 | 973 | 104 | $3,438 |
| Levothyroxine Sodium Generic | 592 | 805 | 84 | $3,275 |
| Furosemide Generic | 498 | 626 | 80 | $1,321 |
| Nifedipine Er Nifedipine | 426 | 571 | 64 | $4,698 |
| Metoprolol Succinate Generic | 413 | 619 | 64 | $3,834 |
| Potassium Chloride Generic | 410 | 536 | 82 | $6,212 |
| Omeprazole Generic | 404 | 653 | 82 | $2,913 |
| Losartan Potassium Generic | 364 | 540 | 59 | $1,791 |
| Rosuvastatin Calcium Generic | 344 | 596 | 63 | $2,326 |
| Pantoprazole Sodium Generic | 338 | 484 | 61 | $2,939 |
| Gabapentin Generic | 308 | 438 | 59 | $5,769 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 306 | 306 | 33 | $3,144 |
| Tramadol Hcl Generic | 302 | 303 | 55 | $2,080 |
| Allopurinol Generic | 259 | 411 | 45 | $1,819 |
Brand drugs: 1,526 claims; generic drugs: 14,912 claims; opioid claims: 916.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid William V Fattig $120 ($120 in general payments such as food, travel and fees) from 5 companies. The largest payer was Viatris Specialty LLC with $30.74.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.